Found: 9
Select item for more details and to access through your institution.
The Anticancer Effect of a Novel Quinoline Derivative 91b1 through Downregulation of Lumican.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 21, p. 13181, doi. 10.3390/ijms232113181
- By:
- Publication type:
- Article
Anti-cancer Effects of a Novel Quinoline Derivative 83b1 on Human Esophageal Squamous Cell Carcinoma through Down-Regulation of COX-2 mRNA and PGE<sub>2</sub>.
- Published in:
- Cancer Research & Treatment, 2017, v. 49, n. 1, p. 219, doi. 10.4143/crt.2016.190
- By:
- Publication type:
- Article
Studies on quinoline type dyes and their characterisation studies on acrylic fabric.
- Published in:
- Coloration Technology, 2012, v. 128, n. 3, p. 192, doi. 10.1111/j.1478-4408.2012.00363.x
- By:
- Publication type:
- Article
The Puzzling Issue of 'Vehicle-Treated Control' when Using Ethanol as Drug Carrier for MCF-7 Cells.
- Published in:
- Phytotherapy Research, 2014, v. 28, n. 11, p. 1735, doi. 10.1002/ptr.5153
- By:
- Publication type:
- Article
Development of a Novel Quinoline Derivative as a P-Glycoprotein Inhibitor to Reverse Multidrug Resistance in Cancer Cells.
- Published in:
- Biology (2079-7737), 2019, v. 8, n. 4, p. 75, doi. 10.3390/biology8040075
- By:
- Publication type:
- Article
Tumor suppressor dual-specificity phosphatase 6 (DUSP6) impairs cell invasion and epithelial-mesenchymal transition (EMT)-associated phenotype.
- Published in:
- International Journal of Cancer, 2012, v. 130, n. 1, p. 83, doi. 10.1002/ijc.25970
- By:
- Publication type:
- Article
GAEC1 drives colon cancer progression.
- Published in:
- Molecular Carcinogenesis, 2019, v. 58, n. 7, p. 1145, doi. 10.1002/mc.22998
- By:
- Publication type:
- Article
Targeting DNA Binding for NF-κB as an Anticancer Approach in Hepatocellular Carcinoma.
- Published in:
- Cells (2073-4409), 2018, v. 7, n. 10, p. 177, doi. 10.3390/cells7100177
- By:
- Publication type:
- Article
Expression of Insulin-Like Growth Factor Binding Protein-5 (IGFBP5) Reverses Cisplatin-Resistance in Esophageal Carcinoma.
- Published in:
- Cells (2073-4409), 2018, v. 7, n. 10, p. 143, doi. 10.3390/cells7100143
- By:
- Publication type:
- Article